About the Centre for Medicinal Cannabis Research and Innovation Advisory Council
The Centre for Medicinal Cannabis Research and Innovation is supported by an Advisory Council which includes respected leaders from medicine, academia and industry, as well as patient welfare advocates.
The Advisory Council meets two to three times per year and:
- advises the Centre for Medicinal Cannabis Research and Innovation on:
- work and research priorities,
- research and industry networks and linkages in Australia and internationally
- reviews and comments on commissioned reports as required.
Advisory Council Members
- Professor Richard Day AM
Professor Richard Day is Professor of Clinical Pharmacology, UNSW and St Vincent’s Hospital and is a Clinical Pharmacologist and Rheumatologist. He co-founded and heads the Masters in Drug Development course at UNSW. Professor Day was chairman of PHARM that advised the Federal Government of Australia on achieving quality use of medicines (QUM). He is Immediate Past President of the Drug Information Association (DIA), an international organization dedicated to the enhancement of the development of needed medicines worldwide. He heads the Division of Clinical Pharmacology in SydPath.
- Dr Bronwyn Evans
In October 2013, Dr Bronwyn Evans FIEAust FTSE took on the role as Chief Executive Officer of Standards Australia. She has more than 30 years’ experience as an engineering executive in the areas of power generation, engineering education, standards creation and medical devices.
She is the Chair of the Industry Growth Centre for Medical Technologies and Pharmaceuticals, a member of the Australia-Japan Foundation, and a director of The Warren Centre for Advanced Engineering.
Professor Evans is a Fellow of The Institution of Engineers Australia, a Fellow of the Australian Academy of Technological Sciences and Engineering, an Honorary Fellow of University of Wollongong. She has a BE (Elec) and PhD in Electrical Engineering from University of Wollongong in the field of industrial automation, and is a graduate of the Australian Institute of Company Directors.
In 2013 she was named the Professional Engineer of the Year, Engineers Australia – Sydney pision, and in 2014 and 2015 was recognised as one of Australia’s 100 most influential engineers.
- Mrs Lucy Haslam
Lucy Haslam is a patient advocate and medicinal cannabis campaigner. A former Registered Nurse with more than 20 years’ experience, she is married to Lou, a former NSW Police Drug squad officer of 35 years. They were both staunch opponents to recreational drug use until 2014, when they were faced with a terminally ill son, struggling with chemotherapy-induced nausea and vomiting.
Daniel’s positive experience with cannabis in a medicinal capacity greatly improved his quality of life until his death in February 2015, and forced the Haslams to revaluate their previous stance on cannabis for medicinal purposes.
Lucy now lobbies Government at all levels to reintroduce medicinal cannabis as a valid form of medicine for very sick Australians with a wide range of serious conditions. She has set up the not-for-profit organisation United in Compassion, which has a priority of establishing a compassionate access program in Australia.
- Dr Charlotte Hespe
Dr Charlotte Hespe was the founding Director of the Central Sydney Division of General Practice (CSGPN) and Sydney Institute of General Practice Education and Training (GP Synergy). She is currently Chair of the Inner West Sydney Medicare Local and GP Synergy and Deputy Chair, NSW/ACT RACGP Faculty. Charlotte is Head of GP research and conjoint Head of General Practice at University of Notre Dame, Australia, School of Medicine Sydney.
- Professor Alison Jones
Professor Alison Jones is Executive Dean of the Faculty of Science, Medicine and Health at the University of Wollongong. She has 24 years’ experience in clinical toxicology and general medicine and remains clinically and research active. Professor Jones is a Fellow of the American Academy of Clinical Toxicology, Fellow of the American College of Medical Toxicology and Fellow of the Royal Australasian College of Physicians. She advises a number of government agencies as an independent toxicology advisor.
- Professor Graham King
Professor Graham King is Director of Plant Science at Southern Cross University, an Honorary Professor at the University of Nottingham, a Chutian Professor Chair in Wuhan, China, and a Research Associate of Crops For the Future in Malaysia. Gaining his PhD from the University of London in 1986, he then established an international profile in crop plant genetics and genomics, including positions at the University of Warwick and Rothamsted Research. Professor King has worked alongside plant breeders and led major national and international research consortia, generating fundamental knowledge applied to the genetic improvement of arable and horticultural crops.
- Professor Laurent Rivory
Professor Laurent Rivory is the Pro Vice-Chancellor (Research) in the Office of the Deputy Vice Chancellor Research. Professor Rivory’s role has a particular focus on the areas where cross-faculty engagement and external partnerships are integral to the academic enterprise. An important aspect of the role is developing and establishing frameworks and governance arrangements that enable appropriate integration with external partners to increase translation into practice, new capability and impact of the University's research and education output.
- Dr Saxon D. Smith
Dr Saxon D. Smith MBChB, MHL, GAICD, FACD, is a fellow of the Australasian College of Dermatologists. He graduated medicine from the University of Otago, Dunedin, New Zealand, has a Masters Degree in Health Law from the University of Sydney, and is a Graduate of the Australian Institute of Company Directors.
Dr Smith is a consultant dermatologist in private practice, a staff specialist at Royal North Shore Hospital, and a clinical senior lecturer at the University of Sydney. He is a clinical researcher and has published widely on various topics including medicine, health policy and ethics.
Dr Smith is the former President of the Australian Medical Association (NSW) and has a particular interest in public health advocacy to reduce the incidence of preventable disease and injury, primarily in the areas of skin cancer awareness, obesity and alcohol-related violence. He has been AMA’s national spokesperson on medicinal cannabis.
- Dr Kendra Sundquist
Dr Kendra Sundquist (Ed.D; UTS, M.Hlth.Science Ed: Sydney University) is Director of Health Program Consultants. She has previously worked in senior management positions in Non-Government Health Organisations such as the Cancer Council NSW and Family Planning NSW. Dr Sundquist has also worked in developing countries providing health education in HIV/AIDS for WHO and AusAID.
Dr Sundquist was appointed to the Medical Board of NSW (now Council), by the Minister for Health in 1999, and served for 12 years. She continues to sit on disciplinary Hearing Panels, and on NCAT Medical Tribunals for the Health Practitioner Councils Authority.
Her current volunteer work includes: member of Cancer Institute NSW Cancer Research Advisory Committee and Community Member of ACI Consumer Council. She is a member of Health Consumers NSW, Cancer Voices, and has worked as a Volunteer Educator, Council on the Ageing NSW.